The α2-Adrenoceptor Antagonist Idazoxan Reverses Catalepsy Induced by Haloperidol in Rats Independent of Striatal Dopamine Release: Role of Serotonergic Mechanisms
- 25 November 2002
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 28 (5) , 872-879
- https://doi.org/10.1038/sj.npp.1300119
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The ?2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions ofL-dopa in the MPTP-lesioned primate model of Parkinson's diseaseMovement Disorders, 1999
- Fluoxetine Increases Extracellular Dopamine in the Prefrontal Cortex by a Mechanism Not Dependent on SerotoninJournal of Neurochemistry, 1999
- The role of α2‐adrenoceptor antagonism in the anti‐cataleptic properties of the atypical neuroleptic agent, clozapine, in the ratBritish Journal of Pharmacology, 1998
- Serotonergic mechanisms in neuroleptic-induced catalepsy in the ratNeuroscience & Biobehavioral Reviews, 1996
- The α2-adrenoceptor antagonist idazoxan is an agonist at 5-HT1A autoreceptors modulating serotonin synthesis in the rat brain in vivoNeuroscience Letters, 1996
- The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet studyLife Sciences, 1995
- Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?Journal of Psychopharmacology, 1994
- The effect of serotonergic agents on haloperidol-induced catalepsyLife Sciences, 1990
- On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the ratJournal of Pharmacy and Pharmacology, 1978
- Serotonergic involvement with neuroleptic catalepsyNeuropharmacology, 1975